The market of 100 billion traditional Chinese medicine formula granules is being highly concerned by institutions

As a modern Chinese medicine, traditional Chinese medicine formula granules have the advantages of convenient consumption and portability compared with decoction pieces, and are less affected by centralized procurement compared with Chinese patent medicines.
market share
.
In addition, Guorong Securities pointed out that the substitution rate of traditional Chinese medicine granules in Japan and South Korea for decoction pieces is about 60%.
It is conservatively estimated that the substitution rate of formula granules in China will be about 50% in the future, and the corresponding market size is expected to exceed 150 billion
.
At present, traditional Chinese medicine formula granules are receiving the attention of institutions
.
Recently, many institutions have mentioned the business of traditional Chinese medicine formula granules in the process of investigating related traditional Chinese medicine companies
.
China Resources Sanjiu: Obtained research from two institutions.
For example, China Resources Sanjiu released an investor research activity announcement on January 20, and GW&K Investment and Bank of Communications Schroders Fund researched the company on January 18, 2022
.
In the interactive session, the agency paid attention to the company's views on the centralized procurement of traditional Chinese medicine formula granules, and the price increase arrangements for products
.
Regarding the centralized procurement of traditional Chinese medicine formula granules, the company said that Shandong Province is promoting the procurement of decoction pieces and formula granules with volume, and the company is actively paying attention to the introduction of detailed rules and other contents
.
At present, the number of national standard varieties is relatively small, and at the same time, hospitals use traditional Chinese medicine pharmacies to serve product sales.
Therefore, based on the small number of existing national standard varieties, it is expected that the active and comprehensive promotion of centralized procurement in the short term may not be fully mature
.
In the future, the number of national standard varieties will reach a certain scale, which will be more conducive to the exploration of centralized procurement
.
In terms of product price increase arrangements, the company mentioned that formula granules will have a certain price increase in the future with the cost
.
Yiling Pharmaceutical: Received an investigation by one institution On January 14, Yiling Pharmaceutical issued an announcement saying that Life Insurance and Pensions investigated the company on January 13, 2022
.
The agency paid attention to the company's plan for the development of the formula granule business and whether it has completed the research and development in accordance with the new national standard
.
In this regard, Yiling Pharmaceutical stated that the formula granule business is one of the business segments of the company's traditional Chinese medicine sector, which currently accounts for a small proportion of the company's overall revenue.

.
The company's research institute has completed the research and development of more than 180 formula granules in accordance with the new national standards, and has now made production records on the platform of the State Food and Drug Administration
.
Yixintang: Responding to the concerns of investors on the interactive platform On January 5, Yixintang answered the questions that investors were concerned about on the investor relations platform
.
Among them, in response to the question of when the company's formula granules will be launched and the output value of production capacity, the company said that the company's self-produced traditional Chinese medicine formula granules have been listed, and there are currently more than 240 customers.
Please pay attention to the company's regular reports for details, thank you
.
From November 1, 2021, the pilot program of traditional Chinese medicine formula granules has ended, which has greatly broadened the market space of traditional Chinese medicine formula granules; "Guiding Opinions", which mentions that traditional Chinese medicine formula granules purchased by public medical institutions are encouraged to be included in the online transaction of provincial centralized pharmaceutical procurement platforms
.
From the perspective of the industry, centralized procurement is based on the exchange of price for quantity.
Judging from the price reduction in Hubei and other places, the price is reduced by about 40%, so the price reduction is relatively mild
.
"Taking Chinese traditional medicine as an example, the gross profit rate of traditional Chinese medicine formula granules is 70%, while the sales expense ratio is 37%
.
Just saving the sales expenses is almost enough to offset this price reduction
.
" Therefore, it is expected that traditional Chinese medicine formula granules will become a new market.
Related companies on the track deserve attention
.